KalVista Pharmaceuticals (KALV) Return on Capital Employed Growth (1y) (2016 - 2025)
KalVista Pharmaceuticals (KALV) Return on Capital Employed Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 2,400.00 |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | -2,516.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -2,516.00 |
| Apr 30, 2025 | 746.00 |
| Oct 31, 2024 | -1,922.00 |
| Jul 31, 2024 | -752.00 |
| Apr 30, 2024 | -3,029.00 |
| Jan 31, 2024 | -5,361.00 |
| Oct 31, 2023 | -2,363.00 |
| Jul 31, 2023 | -1,570.00 |
| Apr 30, 2023 | -1,456.00 |
| Jan 31, 2023 | -2,268.00 |
| Oct 31, 2022 | -3,496.00 |
| Jul 31, 2022 | -3,192.00 |
| Apr 30, 2022 | -1,127.00 |
| Jan 31, 2022 | 3,686.00 |
| Oct 31, 2021 | 3,914.00 |
| Jul 31, 2021 | 3,246.00 |
| Apr 30, 2021 | 868.00 |
| Jan 31, 2021 | -3,211.00 |
| Oct 31, 2020 | -3,487.00 |
| Jul 31, 2020 | -2,611.00 |